Ramses condoms' comparative strength claims "unsubstantiated" -- FTC consent agreement.
This article was originally published in The Gray Sheet
Executive SummaryRAMSES CONDOM COMPARATIVE CLAIMS BARRED BY PROPOSED FTC AGREEMENT unless Norcross, Georgia-based London International "possesses and relies upon competent and reliable scientific evidence to back up the claims" for the latex condoms, the Federal Trade Commission reported Sept. 3. The consent agreement was spurred by advertising claims that Ramses is "30% stronger than the leading brand," which FTC called "unsubstantiated and deceptive."
You may also be interested in...
HAL Allergy Group, developer of products for allergy diagnostics and allergen immunotherapy, promoted its principal scientist to chief R&D officer; Starkey Hearing Technologies brought on new health and business development execs to expand its global footprint; and more.
As the coronavirus continues to spread, one of the big four global vaccines companies has committed itself to the fight.